Today, we’re pleased to share an important leadership update at Pattern. Carey-Ann Burnham, our chief clinical officer since 2022, has been named chief executive officer. With her deep expertise in microbiology and proven leadership, Carey-Ann will lead Pattern through the critical phase of clinical validation. Nicolas Arab, our founder, has transitioned to chief technology officer, focusing on advancing our groundbreaking single-cell microbiology technology. Please join us in congratulating Carey-Ann and recognizing Nick as they take on these new roles! More details: https://lnkd.in/eNksdxP4
Pattern Bioscience
Biotechnology Research
Austin, Texas 4,365 followers
Our mission is simple: We will improve the world's most important health decisions.
About us
Tackling a global health threat like antimicrobial resistance is not for the faint of heart, but the experienced and innovative team at Pattern Bioscience is on a mission to do it. Each year, drug-resistant bacterial infections claim more than a million lives globally and cost our healthcare system billions of dollars. Traditional diagnostic methods for bacterial infections remain rooted in slow, cumbersome, decades-old technology that contributes to sub-optimal treatment and the misuse of broad-spectrum antibiotics. The Pattern system is different. We’re developing the world’s only culture-free, rapid diagnostic technology that will reduce the time needed for pathogen identification (ID) and antibiotic susceptibility test (AST) results from days to hours. Our technology combines single-cell analysis of microorganisms with machine learning tools to deliver fast, clinically actionable information. The result? Patients get the right treatment faster, to save lives, prevent side effects and reduce healthcare costs.
- Website
-
https://pattern.bio
External link for Pattern Bioscience
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Austin, Texas
- Type
- Privately Held
- Founded
- 2016
Locations
-
Primary
Get directions
Austin, Texas 78759, US
Employees at Pattern Bioscience
Updates
-
Pattern Bioscience reposted this
We are partnering with Pattern Bioscience towards development of an FDA-cleared system for rapid identification and phenotypic antimicrobial susceptibility testing (ID/AST) with diagnostic panels for pneumonia and bacteremia. The diagnostic platform would deliver results from individual bacterial cells in 4-6 hours compared to days for traditional AST platforms. For faster treatment and better outcomes for the patients, BARDA is supporting development of diagnostic devices that can identify and characterize the antimicrobial resistance of a bacteria in a short period of time. Learn more about this award: https://ow.ly/WocS50UaTwS
-
-
We’re pleased to announce a partnership with Biomedical Advanced Research and Development Authority (BARDA) to support the late-stage development, verification, validation, and FDA clearance of our single-cell microbiology system and pneumonia and bacteremia identification (ID)/antimicrobial susceptibility testing (AST) panels.
-
Pattern Bioscience reposted this
Thanks for the wonderful meeting, SWACM - Southwestern Association of Clinical Microbiology! Congratulations to Melanie Yarbrough Meghan Wallace Megan Porter Kelly Alvarado for taking the prize for best poster. Big thanks to everyone who stopped by our Pattern Bioscience booth.
-
-
Interested in our cutting-edge single-cell microbiology technology? Join Carey-Ann Burnham this Friday at 5:15pm at ASM Microbe for a spotlight discussion on our award-winning innovation.
-
-
Pattern Bioscience reposted this
Meet the Forty Acres Founders Pitch Competition Judges Panel! 🚀💡 NICK ARAB - Co-Founder & CEO of Pattern Bioscience Nick is the co-founder and CEO of Pattern Bioscience, an Austin-based med-tech startup developing a single-cell microbiology platform to solve antibiotic resistance. Under his guidance, Pattern has raised $68 million, including almost $50 million over multiple equity financings. Nick has over 15 years of experience developing FDA-cleared diagnostic products and technologies. Before founding Pattern in 2016, Nick was at Luminex for 10 years, most recently serving as Senior Director of the company’s Advanced Technology Group. He has innovated across several technical disciplines, twice winning Luminex’s “Top Inventor” award, and has been granted 39 patents with 37 patents pending. Nick obtained his B.S. in Electrical Engineering at UT Austin. Come see what questions Nick has for the founders at the Forty Acres Founders Pitch Competition Finals on April 18th! RSVP today: https://bit.ly/49YV7Pq #FortyAcresFounders #StartupsStartHere #PitchCompetition
-